投资者关系活动记录表 编号：2023-001 证券代码：300214 证券简称：日科化学 山东日科化学股份有限公司 山东日科化学股份有限公司投资者关系活动记录表 | 投资者关系活动类别 | □ 特定对象调研 □ 分析师会议 □ | | 媒体采访 | | --- | --- | --- | --- | | | √业绩说明会 □新闻发布会 □路演活动 | | | | | □现场参观 □其他 | | | | 参与单位名称 | 参与公司 年度业绩网上说明会的投资者 | 2022 | | | 及人员姓名 | | | | | 时间 | 2023 年 5 5 日 | 月 | | | 地点 | 深圳证券交易所"互动易"平台(http://irm.cninfo.com.cn) | | | | 上市公司接待人员姓名 | 董事长蒋荀先生，财务总监刘永强先生，副总经理、董事会秘书田志龙先生， | | | | | 独立董事朱明江先生，保荐代表人王宁华女士。 | | | | | 问：作为一个小股东，每天看到公司的成交量不到一千万、跌跌不休、 | | | | | 在边缘化时心就在滴血；公司 21 年增发的项目（已破发）都还没完工现在又 | ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥583,133,877.71, a decrease of 20.72% compared to ¥735,574,870.44 in the same period last year[5] - The net profit attributable to shareholders for Q1 2023 was ¥17,727,842.35, down 78.10% from ¥80,938,188.27 in the previous year[5] - The company reported a significant decrease in total profit, which was ¥21,499,163.10, down 78.85% from ¥101,674,709.53 in the same period last year[12] - The company’s diluted earnings per share for Q1 2023 was ¥0.04, a decrease of 76.47% compared to ¥0.17 in the previous year[5] - Total operating revenue for Q1 2023 was CNY 583.13 million, a decrease of 20.7% compared to CNY 735.57 million in Q1 2022[22] - Net profit for Q1 2023 was CNY 17.69 million, a decline of 78.1% from CNY 80.94 million in Q1 2022[23] - Earnings per share for Q1 2023 were CNY 0.04, compared to CNY 0.17 in Q1 2022[24] Cash Flow - The net cash flow from operating activities increased significantly by 366.33%, reaching ¥46,909,900.09 compared to ¥10,059,329.13 in Q1 2022[5] - The net cash flow from financing activities surged by 932.94% to ¥54,326,467.00, attributed to increased bank borrowings for project support[13] - The net cash flow from financing activities for the current period is ¥54,326,467.00, up from ¥5,259,412.82 in the previous period, representing an increase of about 935.5%[27] - Total cash inflow from operating activities decreased to ¥560,953,053.94 from ¥636,845,678.15, reflecting a decline of about 11.9%[25] - Cash outflow from operating activities also decreased to ¥514,043,153.85 from ¥626,786,349.02, indicating a reduction of approximately 17.9%[25] - The net cash flow from investment activities is negative at -¥113,453,896.17, compared to a positive ¥60,468,260.70 in the previous period[27] - Cash inflow from financing activities increased to ¥89,470,729.70 from ¥6,034,128.40, marking an increase of approximately 1,480.5%[27] - The ending balance of cash and cash equivalents decreased to ¥102,080,989.23 from ¥152,840,054.13, a decline of approximately 33.1%[27] Assets and Liabilities - The total assets at the end of Q1 2023 were ¥3,064,685,388.36, a slight increase of 0.58% from ¥3,046,987,882.64 at the end of the previous year[5] - The company's total liabilities amounted to CNY 519.06 million, slightly down from CNY 521.06 million in the previous quarter[23] - Total equity attributable to shareholders was CNY 2.55 billion, an increase from CNY 2.53 billion in the previous quarter[23] - Current assets decreased from 1,553,737,085.71 RMB to 1,215,790,275.39 RMB[19] - The total assets of the company reached CNY 3.06 billion, slightly up from CNY 3.05 billion in the previous quarter[23] Shareholder Information - The total number of common shareholders at the end of the reporting period is 14,778[14] - The largest shareholder, Zhao Dongri, holds 17.52% of shares, totaling 81,785,037 shares[14] Investments and Projects - The company plans to invest 950 million RMB in a project to produce 60,000 tons of lithium battery electrolyte raw materials annually[15] - A joint venture was established to invest in a project with an annual capacity of 600,000 tons of film and products, with a total investment of 152 million RMB[16] - The company has invested 6 million RMB to establish a joint venture for steam supply, with a registered capital of 20 million RMB[17] Research and Development - Research and development expenses rose by 117.75% to ¥11,338,619.86, reflecting the company's commitment to enhancing product offerings and adapting to market changes[12] - Research and development expenses increased to CNY 11.34 million, up 117.5% from CNY 5.21 million in the previous year[23]

Financial Performance - The company's operating revenue for 2022 was ¥2,759,520,253.21, a decrease of 0.48% compared to ¥2,772,847,325.93 in 2021[20]. - Net profit attributable to shareholders for 2022 was ¥196,498,216.73, representing a 3.33% increase from ¥190,169,628.70 in 2021[20]. - The net profit after deducting non-recurring gains and losses was ¥198,598,822.10, up 6.31% from ¥186,811,363.32 in 2021[20]. - The net cash flow from operating activities increased by 112.87% to ¥227,690,681.31 from ¥106,960,548.21 in 2021[20]. - Total assets at the end of 2022 were ¥3,046,987,882.64, a 5.36% increase from ¥2,892,064,345.84 at the end of 2021[20]. - The net assets attributable to shareholders increased by 6.99% to ¥2,526,029,162.52 from ¥2,360,999,581.38 at the end of 2021[20]. - The company reported a basic earnings per share of ¥0.42, down 10.64% from ¥0.47 in 2021[20]. - The weighted average return on equity was 8.04%, a decrease of 0.88% from 8.92% in 2021[20]. - The company achieved a total revenue of ¥2,759,520,253.21, a decrease of 0.48% compared to the previous year, with overall sales volume remaining stable[39]. - The gross profit margin of the main products decreased by 0.63 percentage points compared to the previous year[52]. Dividend Distribution - The company reported a profit distribution plan, proposing a cash dividend of 0.6 RMB per 10 shares based on a total of 466,802,614 shares[3]. - The company distributed cash dividends of RMB 28,008,156.84, with a dividend of RMB 0.60 per 10 shares based on a total share base of 466,802,614 shares[170]. - The cash dividend distribution accounted for 100% of the total profit distribution amount, adhering to the company's policy of a minimum 40% cash dividend in mature stages[170]. Research and Development - The company is focused on enhancing its core capabilities in providing comprehensive solutions from raw material selection to product development[14]. - The company is investing in R&D for plastic and rubber processing equipment, raw materials, and formulations to meet evolving consumer demands[32]. - Research and development expenses increased by 62.66% to ¥39,840,360.15, reflecting the company's commitment to product innovation[67]. - The company has 7 invention patents and 4 utility model patents for ACR products, and 14 invention patents and 15 utility model patents for ACM products, indicating strong R&D capabilities[44]. - The company has applied for multiple patents, including one for a high-performance recyclable crosslinking agent, indicating a strong commitment to innovation[69]. Market Position and Products - The company is positioned in the plastic and rubber modifier industry, with significant growth potential in high-end green building materials due to increasing safety and environmental standards[31]. - The company's main products include ACR and ACM, which are used as processing aids and impact modifiers in PVC applications[14]. - ACR series products generated revenue of ¥1,384,373,773.07, reflecting a 7.29% increase year-on-year, driven by strong demand in the building decoration materials sector[39]. - ACM series products saw a revenue decline of 8.15% to ¥1,269,434,329.59, with sales volume decreasing by 6.17% due to downstream demand fluctuations[39]. - ACR and ACM series products accounted for 50.17% and 46% of the company's total revenue, respectively[34]. Risks and Challenges - The company acknowledges potential risks including macroeconomic uncertainties and increased competition affecting product gross margins[3]. - The company faces pressures from macroeconomic downturns and geopolitical tensions, necessitating enhancements in overall industry competitiveness[31]. - The company is exposed to raw material price volatility, which could impact production costs and gross margins[118]. - Increasing accounts receivable may lead to liquidity risks, prompting the company to enhance customer selection and collection efforts[119]. - Environmental risks are present due to the nature of the chemical industry, necessitating ongoing investment in compliance with rising standards[121]. Corporate Governance - The company has established a governance structure that complies with relevant laws and regulations, ensuring independent operation from its controlling shareholder[126]. - The board of directors consists of 5 members, including 2 independent directors, meeting the legal requirements[129]. - The supervisory board has 3 members, including 1 employee representative, complying with legal regulations[130]. - The company has established a comprehensive information disclosure management system to ensure accurate and timely information for investors[132]. - The company emphasizes the importance of timely and efficient decision-making to protect the rights of shareholders[160]. Employee Management - The total number of employees at the end of the reporting period was 1,092, with 481 in the parent company and 611 in major subsidiaries[164]. - The company has a total of 807 production staff, 54 sales personnel, 143 technical staff, 18 financial staff, and 70 administrative staff[164]. - The company conducted internal training programs to enhance employee skills and overall performance[167]. - The company has a total of 1 employee with a doctoral degree, 1 with a master's degree, and 375 with undergraduate or vocational education[165]. Investment and Projects - The company is actively constructing a 330,000-ton high polymer new material project, with the first phase (45,000 tons/year PMMA) currently under construction[52]. - The company is also advancing a 200,000-ton ACM device and a 200,000-ton rubber sheet project, both currently under construction[52]. - The company has committed to a project with a total investment of 28,312 million CNY, with an expected completion date extended to December 2023 due to regulatory delays[88]. - The company has established a new subsidiary, Shandong Huinengda New Materials Technology Co., Ltd., to diversify its operations[95]. Financial Management - The company has a registered capital of 1,088,751,626.71 RMB, reflecting substantial financial backing for its operations[107]. - The company has a capital reserve balance of RMB 830,514,729.58, reflecting its financial stability[170]. - The company has not utilized any of the raised funds for temporary liquidity support, instead opting to invest in bank wealth management products[90]. - The current auditor is Dahua Certified Public Accountants with an audit fee of 430,000 RMB, and they have been providing services for 2 consecutive years[195]. Social Responsibility and Compliance - The company is committed to fulfilling its social responsibilities while promoting development alongside shareholders, employees, and the community[180]. - The company actively participates in social welfare initiatives and collaborates with local governments and organizations[186]. - The company has established a complete environmental management system to continuously improve resource utilization efficiency and respond to environmental risks[185]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[180].

欢迎广大投资者积极参与。 特此公告。 证券代码：300214 证券简称：日科化学 公告编号：2023-022 山东日科化学股份有限公司 关于举办 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 山东日科化学股份有限公司（以下简称"公司"）《2022 年年度报告》及 《2022 年年度报告摘要》已于 2023 年 4 月 21 日在中国证监会指定的创业板信 息披露网站披露。为了更好地与广大投资者进行交流，便于投资者进一步了解公 司的生产经营情况，公司定于 2023 年 5 月 5 日（星期五）下午 15:00-17:00 举办 2022 年度业绩说明会。本次年度业绩说明会将采用网络远程的方式举行，投资 者可登录深圳证券交易所"互动易"平台（http://irm.cninfo.com.cn），进入"云 访谈"栏目参与本次年度业绩说明会。 参加本次业绩说明会的人员情况如下：董事长蒋荀先生，财务总监刘永强先 生，副总经理、董事会秘书田志龙先生，独立董事朱明江先生，保荐代表人王宁 华女士。 为充分尊重投资者、提升交流的针对性，现就公司 ...

山东日科化学股份有限公司投资者关系活动记录表 编号：2014-001 证券代码：300214 证券简称：日科化学 山东日科化学股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |--------------------------|------------------------------------------------------------------------------|------------------------------------------------------------------|------------------------------------| | 投资者关系活动类别 | √特定对象调研 □分析师 \n□业绩说明会 □新闻发布会 □路演活动 \n□现场参观 □其他 | | 会议 □媒体采访 | | 参与单位名称 及人员姓名 | 国泰君安证券-陆建巍 | | | | 时间 | 2014 年 9 月 12 日 | | | | 地点 公司会议室 | | | | | 上市公司接待人员姓名 | 董事、副总经理、董事会秘书-刘安成 | ...

Group 1: Company Performance - In 2015, the company achieved a revenue growth of 60.44% compared to the same period last year, driven by strategic procurement and lower raw material costs [2] - The company's revenue for the first quarter of 2015 increased by 34.39% year-on-year, with a significant rise in net profit compared to the previous year [2] - The sales of ACR and ACM products saw the highest revenue growth in the first quarter of 2015, while AMB product revenue experienced a slight increase [2] Group 2: Market Strategy - The company is transitioning from merely selling products to providing comprehensive solutions for customer problems [2] - A focus on customer satisfaction is emphasized, aiming for 120% satisfaction by aligning marketing strategies with customer needs [3] - The company is implementing a strategy of vertical integration, creating a sales platform for upstream suppliers and a procurement platform for downstream customers [3] Group 3: Raw Material Management - The company actively monitors fluctuations in raw material prices and adjusts product pricing accordingly, based on market conditions and customer capacity [2] - Strategic procurement is employed to mitigate the impact of raw material price volatility, leveraging scale advantages to create value for suppliers and customers [2] Group 4: Tax Policies - The company, as a general VAT taxpayer, applies a 17% tax rate on product sales revenue and benefits from the "exemption, offset, and refund" tax policy for exported products [3] - The export tax rebate rate for primary acrylic polymers was adjusted from 11% to 5% on July 1, 2007, and increased to 13% for primary acrylic polymer products on April 1, 2015 [4]

山东日科化学股份有限公司投资者关系活动记录表 编号：2015-002 证券代码：300214 证券简称：日科化学 山东日科化学股份有限公司 投资者关系活动记录表 | --- | --- | --- | --- | |-------------------------|----------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Group 1: Company Overview - The main business of Shandong Rike Chemical Co., Ltd. includes modified agents, with key products such as PVC toughening agents and ACR impact modifiers [2] - The company underwent a change in controlling shareholder to Jinhu Investment in November 2018, initiating a long-term cooperation model with Ru Min Investment [2] Group 2: Strategic Development - Ru Min Investment is optimistic about the company's prospects in the fine chemical industry and recognizes its long-term investment value [2] - The collaboration aims to enhance the company's strategic development, extend the industrial chain, and improve overall company value [2] Group 3: Competitive Advantages - The company possesses significant technical advantages, with ACR products having the highest molecular weight and viscosity in the industry, which can lower customer production costs [3] - The core team, led by founder Zhao Dongri, has deep industry understanding and experience, enhancing customer responsiveness [3] Group 4: Production Capacity and Projects - The company has launched a project with an annual capacity of 100,000 tons of ACM and 10,000 tons of CPVC, which is expected to significantly impact sales and revenue [4] - A new project for an annual capacity of 330,000 tons of high polymer new materials is planned, with an investment of 1.2 billion yuan, which will greatly enhance revenue and profitability [5] Group 5: Financial Position and Risks - The company has a low debt-to-asset ratio and strong financing capabilities, planning to fund projects through self-financing and bank loans [6] - Being included in the safety production dishonesty blacklist may affect project applications and government funding for one year, but is not expected to significantly impact current operations due to good asset status [6]

山东日科化学股份有限公司投资者关系活动记录表 | --- | --- | --- | --- | --- | |---------------------------|------------------------------------------------------------------------------------------------------------------------|-------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

证券代码：300214 证券简称：日科化学 公告编号：2022-085 山东日科化学股份有限公司 关于参加山东辖区上市公司2022 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，山东日科化学股份有限公司（以下简称 "公司"）将参加由山东证监局、山东上市公司协会联合举办的"山东辖区上市 公司2022年度投资者网上集体接待日活动"，现将有关事项公告如下： 本次集体接待日活动将通过全景路演平台线上交流，投资者可以登录全景网 "投资者关系互动平台"（http://ir.p5w.net），参与本次投资者集体接待日活动。 活动时间为2022年11月16日（星期三）14:00至16:00。 届时公司副总经理兼董事会秘书田志龙先生和财务总监刘永强先生将通过 网络在线交流形式与投资者就公司治理、发展战略、经营状况、股权激励和可持 续发展等投资者关注的问题进行沟通，欢迎广大投资者积极参与。 特此公告。 山东日科化学股份有限公司 董 事 会 二○二二年十一月十四日 ...